Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Pentostatin Low-Dose TBI Is an Effective Conditioning Regimen That Permits Donor Engraftment in Patients with High Co-Morbidities Undergoing the First Transplant or Prior to a Second Transplant

Ani Gvajaia, Joseph Rimando, William Blum, Colin A. Vale, Cynthia R. Giver, Elaina L. Corbett, Kevin Hall, Kristina Murphy, Mary Jo Lechowicz, Michel Conn, Minal Surati, Muna Qayed, Amelia Langston, Edmund K. Waller

Blood (2024) 144 (Supplement 1): 7325.

https://doi.org/10.1182/blood-2024-211880

Published: 2024

Journal Articles

Development of Humanized Antibodies Against Vasoactive Intestinal Polypeptide for Increased T Cell Anti-Leukemia Activity

Justin Adeyeye, Cynthia R. Giver, Jamie Cohen, Yuou Wang, Tysheena P. Charles, Khue G. Nguyen, Jian-Ming Li, Jens Wrammert, David A. Zaharoff, Edmund K. Waller

Blood (2024) 144 (Supplement 1): 4964.

https://doi.org/10.1182/blood-2024-203518

Published: 2024

Journal Articles

The Dominant Effect of the Gut Microbiome on GvHD in Mouse Models of Allo-BMT

Shayna Jankowski, Shuhua Wang, Yiwen Helen Li, Cynthia R. Giver, Edmund K. Waller

Blood (2024) 144 (Supplement 1): 4914.

https://doi.org/10.1182/blood-2024-212102

Published: 2024

Journal Articles

Intermittent Sargramostim Administration Expands Proliferating Naïve T Cells, Tregs, HLA-DR+ PD-L1+ Monocytes and Myeloid-Derived Suppressor Cells: Results from a Randomized Placebo-Controlled Clinical Trial of GM-CSF in Patients with Peripheral Artery Disease

Alireza Rahbar, Mohammad S. Hossain, Cynthia R. Giver, Shivang Desai, Yazan Haroun, Tanveer Kauser, Kiran Ejaz, Arshed A. Quyyumi, Edmund K. Waller

Blood (2023) 142 (Supplement 1): 5355.

https://doi.org/10.1182/blood-2023-186848

Published: 2023

Journal Articles

High Potency Vasoactive Intestinal Peptide Receptor Antagonists Induce Durable Antileukemia/Tumor T Cell Memory in Mice with Once Daily Dosing

Jian-Ming LI, Tenzin Passang, Pankoj Kumar Das, Shuhua Wang, Anish Sen-Majumdar, Nikolaos Papadantoonakis, Cynthia R. Giver, Edmund K. Waller

Blood (2022) 140 (Supplement 1): 4955–4956.

https://doi.org/10.1182/blood-2022-170718

Published: 2022

Journal Articles

PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study

Blood (2022) 140 (Supplement 1): 11187–11189.

https://doi.org/10.1182/blood-2022-165567

Published: 2022

Journal Articles

Indole-3-Carbinol Supplement Reduces GvHD Related Mortality in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Pankoj Kumar Das, Saketh Kollipara, Alyson Swimm, Jian-Ming Li, Shuhua Wang, Saja K. Asakrah, David L Jaye, Cynthia R. Giver, Daniel Kalman, Edmund K. Waller

Blood (2022) 140 (Supplement 1): 4457–4458.

https://doi.org/10.1182/blood-2022-166698

Published: 2022

Journal Articles

Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression

Jingru Zhu, Yitong Wang, Jingxia Li, Pankoj Kumar Das, Hanwen Zhang, Tenzin Passang, Jian Ming Li, Tamas Nagy, Khanjan Gandhi, Sruthi Ravindranathan, Cynthia R. Giver, Mojibade Hassan, Yiwen Li, Alina Ulezko Antonova, Shuhua Wang, John D. Roback, Edmund K. Waller

Blood (2022) 140 (12): 1431–1447.

https://doi.org/10.1182/blood.2021012561

Published: 2022

Includes: Supplemental data

Journal Articles

Donor Plasmacytoid Dendritic Cells Regulate GvHD in a VIP Dependent Manner in Allogeneic BMT Recipients

Jingru Zhu, Pankoj Kumar Das, Yitong Wang, Jingxia Li, Tamas Nagy, Khajan Ghandhi, Sruthi Ravindranathan, Cynthia R. Giver, Jian-Ming Li, Yiwen Li, Alina Ulezko Antonova, John D Roback, Shuhua Wang, Edmund K. Waller

Blood (2021) 138 (Supplement 1): 1687.

https://doi.org/10.1182/blood-2021-152945

Published: 2021

Journal Articles

Transplanted Vasoactive Intestinal Peptide-Secreting Donor Plasmacytoid Dendritic Cells Migrate to Lymphoid Organs and GvHD Target Organs

Jingru Zhu, Yitong Wang, MD, Jingxia Li, MD, Yiwen Li, Alina Ulezko Antonova, Cynthia R. Giver, PhD, Jianming Li, PhD, Shuhua Wang, MD, Edmund K. Waller, PhDMD

Blood (2019) 134 (Supplement_1): 1918.

https://doi.org/10.1182/blood-2019-129628

Published: 2019

Journal Articles

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Cynthia R. Giver, PhD, Pamela A Shaw, PhD, Helen Fletcher, PhD, Deepak Kaushal, PhD, Garcia Pamela, Deborah Omoyege, Gregory Bisson, MD, Tawanda Gumbo, MD, Robert Wallis, MD, Edmund K. Waller, PhDMD, Daniel Kalman, PhD

Blood (2019) 134 (Supplement_1): 1050.

https://doi.org/10.1182/blood-2019-130275

Published: 2019

Journal Articles

Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease

Alyson Swimm, Cynthia R. Giver, Zachariah DeFilipp, Sravanti Rangaraju, Akshay Sharma, Alina Ulezko Antonova, Robert Sonowal, Christopher Capaldo, Domonica Powell, Muna Qayed, Daniel Kalman, Edmund K. Waller

Blood (2018) 132 (23): 2506–2519.

https://doi.org/10.1182/blood-2018-03-838193

Published: 2018

Includes: Supplemental data

Journal Articles

Hierarchical Differences in Defensin Gene Expression in Plasmacytoid Dendritic Cells and Progenitor Cells from Five Different Hematopoietic Stem Cell Transplant Graft Types

Cynthia R. Giver, PhD, Ernestine Anna Mahar, B.S., Sakura Hosoba, MD, Jeanne Kowalski, PhD, Sandra Seby, MSc, Xinyan A. Zhang, PhD MPH, Steven M. Devine, MD, Edmund K. Waller, MD

Blood (2017) 130 (Supplement 1): 1924.

https://doi.org/10.1182/blood.V130.Suppl_1.1924.1924

Published: 2017

Journal Articles

Efficacy of Early Post-Transplant Vaccination Using a Prime and Boost Strategy Is Independent of a Prior History of GvHD: Results from BMT CTN 0201

Edmund K. Waller, MD, Brent R. Logan, PhD, Mingwei Fei, MS, Alan Howard, PhD, John R. Wingard, MD, Claudio Anasetti, MD, Cynthia R. Giver, PhD

Blood (2017) 130 (Supplement 1): 1972.

https://doi.org/10.1182/blood.V130.Suppl_1.1972.1972

Published: 2017

Journal Articles

Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201

Shanelle M. Fernando, Brent R. Logan, PhD, Mingwei Fei, MS, Stephanie J. Lee, MD PhD, Dennis Confer, MD, Alan Howard, PhD, Shanmuganathan Chandrakasan, MD, Cynthia R. Giver, PhD, Claudio Anasetti, MD, Edmund K. Waller, MD

Blood (2017) 130 (Supplement 1): 516.

https://doi.org/10.1182/blood.V130.Suppl_1.516.516

Published: 2017

Journal Articles

Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells

Scott N. Furlan, Benjamin Watkins, Victor Tkachev, Sarah Cooley, Angela Panoskaltsis-Mortari, Kayla Betz, Melanie Brown, Daniel J. Hunt, John B. Schell, Katie Zeleski, Alison Yu, Cynthia R. Giver, Edmund K. Waller, Jeffrey S. Miller, Bruce R. Blazar, Leslie S. Kean

Blood (2016) 128 (21): 2568–2579.

https://doi.org/10.1182/blood-2016-07-726547

Published: 2016

Includes: Supplemental data

Journal Articles

Lateral Gene Transfer Contributing to Leukemogenesis

Joo Hyun Lee, BS, Cynthia R. Giver, PhD, Sravanti Rangaraju, MD MBBS, Edmund K Waller, MD PhD

Blood (2015) 126 (23): 1235.

https://doi.org/10.1182/blood.V126.23.1235.1235

Published: 2015

Journal Articles

Blocking VIP Signaling during Allogeneic Bone Marrow Transplantation Separates the Graft Versus Leukemia from Graft Versus Host Disease Activity of Donor CD8 T-Cells

Jian-Ming Li, PhD, Christopher T Petersen, Graduate, Jingxia Li, Graduate, Cynthia R. Giver, PhD, Bruce R. Blazar, MD, Edmund K Waller, MD PhD

Blood (2015) 126 (23): 1877.

https://doi.org/10.1182/blood.V126.23.1877.1877

Published: 2015

Journal Articles

T Cell Activation By Plasmacytoid Dendritic Cells Is Augmented By Inhibition of Vasoactive Intestinal Polypeptide Signaling: Implications for Cellular Immunotherapy

Jingxia Li, Reema Panjwani, Jian-Ming Li, PhD, Cynthia R. Giver, PhD, Maryellen Malone, Edmund K Waller, MD PhD

Blood (2015) 126 (23): 3438.

https://doi.org/10.1182/blood.V126.23.3438.3438

Published: 2015

Journal Articles

Administration of a Tryptophan Metabolite, Indole-3-Carboxaldehyde, Reduces Graft Versus Host Disease Morbidity and Mortality and Enhances Gastrointestinal Barrier Function in a Murine Model of Allogeneic Bone Marrow Transplantation

Edmund K. Waller, MD PhD, Cynthia R. Giver, PhD, Sravanti Rangaraju, MBBS, Alyson Swimm, BS, Akshay Sharma, MD, Muna Qayed, MD, Zachariah Defilipp, MD, Daniel Kalman, PhD

Blood (2014) 124 (21): 2420.

https://doi.org/10.1182/blood.V124.21.2420.2420

Published: 2014

NARROW

Pentostatin Low-Dose TBI Is an Effective Conditioning Regimen That Permits Donor Engraftment in Patients with High Co-Morbidities Undergoing the First Transplant or Prior to a Second Transplant

Development of Humanized Antibodies Against Vasoactive Intestinal Polypeptide for Increased T Cell Anti-Leukemia Activity

The Dominant Effect of the Gut Microbiome on GvHD in Mouse Models of Allo-BMT

Intermittent Sargramostim Administration Expands Proliferating Naïve T Cells, Tregs, HLA-DR+ PD-L1+ Monocytes and Myeloid-Derived Suppressor Cells: Results from a Randomized Placebo-Controlled Clinical Trial of GM-CSF in Patients with Peripheral Artery Disease

High Potency Vasoactive Intestinal Peptide Receptor Antagonists Induce Durable Antileukemia/Tumor T Cell Memory in Mice with Once Daily Dosing

PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study

Indole-3-Carbinol Supplement Reduces GvHD Related Mortality in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression

Donor Plasmacytoid Dendritic Cells Regulate GvHD in a VIP Dependent Manner in Allogeneic BMT Recipients

Transplanted Vasoactive Intestinal Peptide-Secreting Donor Plasmacytoid Dendritic Cells Migrate to Lymphoid Organs and GvHD Target Organs

IMPACT-TB: A Phase II Trial Assessing the Capacity of Low Dose Imatinib to Induce Myelopoiesis and Enhance Host Anti-Microbial Immunity Against Tuberculosis. Imatinib Mesylate per Oral As a Clinical Therapeutic for TB

Indoles derived from intestinal microbiota act via type I interferon signaling to limit graft-versus-host disease

Hierarchical Differences in Defensin Gene Expression in Plasmacytoid Dendritic Cells and Progenitor Cells from Five Different Hematopoietic Stem Cell Transplant Graft Types

Efficacy of Early Post-Transplant Vaccination Using a Prime and Boost Strategy Is Independent of a Prior History of GvHD: Results from BMT CTN 0201

Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201

Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells

Lateral Gene Transfer Contributing to Leukemogenesis

Blocking VIP Signaling during Allogeneic Bone Marrow Transplantation Separates the Graft Versus Leukemia from Graft Versus Host Disease Activity of Donor CD8 T-Cells

T Cell Activation By Plasmacytoid Dendritic Cells Is Augmented By Inhibition of Vasoactive Intestinal Polypeptide Signaling: Implications for Cellular Immunotherapy

Administration of a Tryptophan Metabolite, Indole-3-Carboxaldehyde, Reduces Graft Versus Host Disease Morbidity and Mortality and Enhances Gastrointestinal Barrier Function in a Murine Model of Allogeneic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only